Copyright
©The Author(s) 2026.
World J Clin Oncol. Jan 24, 2026; 17(1): 114369
Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.114369
Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.114369
Table 1 Clinical parameters of mature cystic sacrococcygeal teratoma in adults, n (%)
| Clinical parameters | Variable |
| Total number of patients | 64 (100) |
| Sex; female | 42 (65.6) |
| Age (year) | 38 (22-68) |
| BMI (kg/m2), median (range) | 23.65 (16.8-31.5) |
| Hypertension | 12 (18.8) |
| Diabetes | 14 (21.9) |
| History of abdominal surgery | 8 (12.5) |
| Maximum tumor diameter (cm), median (range) | 10.85 (3.3-23.5) |
| Altman’ classification | |
| I-II | 41 (64.1) |
| III/IV | 23 (35.9) |
| Pathology | |
| Mature | 64 (100) |
| Surgical approach | |
| Type A | 13 (20.3) |
| Type B | 22 (34.4) |
| Type C | 29 (45.3) |
| Sacrococcygeal resection | 43 (67.2) |
| Intraoperative blood loss (mL) | |
| ≥ 400 mL | 7 (10.9) |
| Sacrococcygeal incision necrosis | 15 (23.4) |
| Intestinal fistula | 5 (7.8) |
| Anorectal dysfunction | 16 (25.0) |
| Urinary dysfunction | 13 (20.3) |
| Lower limb motor dysfuction | 9 (14.1) |
| Reccurence of tumor | |
| Benign | 15 (23.4) |
| Malignancy | 1 (1.6) |
Table 2 Time interval in patients with recurrence
| Patients with recurrence | Recurrence period (months) |
| 1 | 36 |
| 2 | 66 |
| 3 | 28.8 |
| 4 | 37.2 |
| 5 | 18 |
| 6 | 10.8 |
| 7 | 62.4 |
| 8 | 43.2 |
| 9 | 91.2 |
| 10 | 15.6 |
| 11 | 31.2 |
| 12 | 21.6 |
| 13 | 13.2 |
| 14 | 25.2 |
| 15 | 30 |
| 16 | 8.4 |
Table 3 Clinical outcome analysis of three surgical approaches
| Variables | Type A (n = 13) | Type B (n = 22) | Type C (n = 29) | P value |
| Intraoperative blood loss ≥ 400 mL | 2 | 2 | 3 | 0.767 |
| Sacrococcygeal incision necrosis | - | 8 | 7 | 0.371 |
| Intestinal fistula | 2 | 0 | 3 | 0.165 |
| Anorectal dysfunction | 4 | 4 | 8 | 0.655 |
| Urinary dysfunction | 5 | 3 | 5 | 0.218 |
| Lower limb motor dysfuction | 3 | 1 | 5 | 0.240 |
| Reccurence of tumor | 6 | 3 | 7 | 0.108 |
Table 4 Logistic regression analysis of anorectal dysfunction
| Variables | Univariable | Multivariable | |||
| OR (95%CI) | P value | OR (95%CI) | P value | ||
| Sex; female | Yes | 1.800 (0.504-6.432) | 0.366 | ||
| Age ≥ 40 (year) | Yes | 0.600 (0.188-1.913) | 0.388 | ||
| BMI ≥ 25 (kg/m2) | Yes | 0.916 (0.285-2.938) | 0.882 | ||
| Hypertension | Yes | 1.000 (0.235-4.261) | 1.000 | ||
| Diabetes mellitus | Yes | 0.897 (0.245-3.288) | 0.870 | ||
| History of abdominal surgery | Yes | 1.000 (0.181-5.533) | 1.000 | ||
| Maximum tumor diameter ≥ 10 (cm) | Yes | 3.545 (1.000-12.575) | 0.050a | 8.068 (1.648-39.491) | 0.010a |
| Altman’ classification | III/IV vs I-II | 4.487 (1.357-14.834) | 0.014a | 9.484 (2.103-42.774) | 0.033a |
| Surgical approach | Type A | 1 | |||
| Type B | 0.500 (0.101-2.477) | 0.396 | |||
| Type C | 0.857 (0.205-3.589) | 0.833 | |||
| Sacrococcygeal resection | Yes | 0.529 (0.165-1.701) | 0.286 | ||
| Intraoperative blood loss ≥ 400 (mL) | Yes | 5.000 (0.983-25.437) | 0.052 | ||
Table 5 Logistic regression analysis of urinary dysfunction
| Variables | Univariable | Multivariable | |||
| OR (95%CI) | P value | OR (95%CI) | P value | ||
| Sex; female | Yes | 0.800 (0.227-2.820 | 0.728 | ||
| Age ≥ 40 (year) | Yes | 0.964 (0.284-3.270) | 0.953 | ||
| BMI ≥ 25 (kg/m2) | Yes | 0.221 (0.044-1.101) | 0.065 | ||
| Hypertension | Yes | 0.303 (0.035-2.592) | 0.276 | ||
| Diabetes mellitus | Yes | 2.301 (0.558-7.388) | 0.282 | ||
| History of abdominal surgery | Yes | 1.364 (0.242-7.698) | 0.725 | ||
| Maximum tumor diameter ≥ 10 (cm) | Yes | 3.750 (0.922-15.245) | 0.065a | 9.622 (1.694-54.663) | 0.011a |
| Altman’ classification | III/IV vs I-II | 5.946 (1.575-22.454) | 0.009a | 13.264 (2.581-68.168) | 0.002a |
| Surgical approach | Type A | 1.000 | |||
| Type B | 0.253 (0.048-1.319) | 0.103 | |||
| Type C | 0.333 (0.076-1.458) | 0.144 | |||
| Sacrococcygeal resection | Yes | 0.731 (0.207-2.590) | 0.628 | ||
| Intraoperative blood loss ≥ 400 (mL) | Yes | 1.673 (0.286-9.789) | 0.568 | ||
Table 6 Logistic regression analysis of lower extremity motor dysfunction
| Variables | Univariable | Multivariable | |||
| OR (95%CI) | P value | OR (95%CI) | P value | ||
| Sex; female | Yes | 2.000 (0.378-10.569) | 0.414 | ||
| Age ≥ 40 (year) | Yes | 0.519 (0.118-2.285) | 0.385 | ||
| BMI ≥ 25 (kg/m2) | Yes | 0.398 (0.076-2.091) | 0.276 | ||
| Hypertension | Yes | 0.500 (0.056-4.429) | 0.533 | ||
| Diabetes mellitus | Yes | 0.305 (0.035-2.639) | 0.281 | ||
| History of abdominal surgery | Yes | 0.857 (0.093-7.931) | 0.892 | ||
| Maximum tumor diameter ≥ 10 (cm) | Yes | 1.929 (0.438-8.500) | 0.385 | ||
| Altman’ classification | III/IV vs I-II | 8.531 (1.597-45.580) | 0.012a | 16.792 (1.847-152.666) | 0.012a |
| Surgical approach | Type A | 1.000 | |||
| Type B | 0.159 (0.015-1.724) | 0.130 | |||
| Type C | 0.694 (0.139-3.475) | 0.657 | |||
| Sacrococcygeal resection | Yes | 0.559 (0.133-2.346) | 0.427 | ||
| Intraoperative blood loss ≥ 400 (mL) | Yes | 6.375 (1.142-35.581) | 0.035a | 17.366 (1.490-202.372) | 0.023a |
Table 7 Logistic regression analysis of tumor recurrence
| Variables | Univariable | Multivariable | |||
| OR (95%CI) | P value | OR (95%CI) | P value | ||
| Sex; female | Yes | 1.206 (0.359-4.051) | 0.761 | ||
| Age ≥ 40 (year) | Yes | 1.653 (0.528-5.171) | 0.388 | ||
| BMI ≥ 25 (kg/m2) | Yes | 1.296 (0.411-4.084) | 0.658 | ||
| Hypertension | Yes | 0.543 (0.106-2.791) | 0.465 | ||
| Diabetes mellitus | Yes | 2.018 (0.599-6.805) | 0.258 | ||
| History of abdominal surgery | Yes | 1.000 (0.181-5.533) | 1.000 | ||
| Maximum tumor diameter ≥ 10 (cm) | Yes | 1.183 (0.379-3.693) | 0.773 | ||
| Altman’ classification | III/IV vs I-II | 2.200 (0.693-6.979) | 0.181 | ||
| Surgical approach | Type A | 1.000 | |||
| Type B | 0.184 (0.036-0.944) | 0.043a | |||
| Type C | 0.371 (0.093-1.480) | 0.160 | |||
| Sacrococcygeal resection | Yes | 0.120 (0.034-0.424) | 0.001a | 0.084 (0.015-0.475) | 0.005a |
| Intraoperative blood loss ≥ 400 (mL) | Yes | 1.229 (0.214-7.050) | 0.817 | ||
- Citation: Wang Y, Wang Z, Tang YC, Li Y, Guo XB. Mature cystic sacrococcygeal teratoma in adults: A single-center study. World J Clin Oncol 2026; 17(1): 114369
- URL: https://www.wjgnet.com/2218-4333/full/v17/i1/114369.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i1.114369
